المؤلفون: Cardone C., Blauensteiner B., Moreno-Viedma V., Martini G., Simeon V., Vitiello P. P., Ciardiello D., Belli V., Matrone N., Troiani T., Morgillo F., Zito Marino F., Dentice M., Nappi A., Boccaccino A., Antoniotti C., Cremolini C., Pietrantonio F., Prager G. W., Normanno N., Maiello E., Argiles G., Elez E., Signoriello G., Franco R., Falcone A., Tabernero J., Sibilia M., Ciardiello F., Martinelli E., ZITO MARINO, Federica

المساهمون: Cardone, Claudia, Blauensteiner, Bernadette, Moreno-Viedma, Veronica, Martini, Giulia, Simeon, Vittorio, Vitiello, Pietro P, Ciardiello, Davide, Belli, Valentina, Matrone, Nunzia, Troiani, Teresa, Morgillo, Floriana, Zito Marino, Federica, Dentice, Monica, Nappi, Annarita, Boccaccino, Alessandra, Antoniotti, Carlotta, Cremolini, Chiara, Pietrantonio, Filippo, Prager, Gerald W, Normanno, Nicola, Maiello, Evaristo, Argiles, Guillem, Elez, Elena, Signoriello, Giuseppe, Franco, Renato, Falcone, Alfredo, Tabernero, Josep, Sibilia, Maria, Ciardiello, Fortunato, Martinelli, Erika, Cardone, C., Blauensteiner, B., Moreno-Viedma, V., Martini, G., Simeon, V., Vitiello, P. P., Ciardiello, D., Belli, V., Matrone, N., Troiani, T., Morgillo, F., Zito Marino, F., Dentice, M., Nappi, A., Boccaccino, A., Antoniotti, C., Cremolini, C., Pietrantonio, F., Prager, G. W., Normanno, N., Maiello, E., Argiles, G., Elez, E., Signoriello, G., Franco, R., Falcone, A., Tabernero, J., Sibilia, M., Ciardiello, F., Martinelli, E., ZITO MARINO, Federica

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, Population, 03 medical and health sciences, Mice, 0302 clinical medicine, Growth factor receptor, Internal medicine, Cell Line, Tumor, Proto-Oncogene Proteins, Medicine, Animals, Humans, Epithelial–mesenchymal transition, Neoplasm Metastasis, education, education.field_of_study, Cetuximab, business.industry, AXL, EGFR resistance, RAS WT, Receptor Protein-Tyrosine Kinases, Transfection, medicine.disease, Xenograft Model Antitumor Assays, Axl Receptor Tyrosine Kinase, Blockade, ErbB Receptors, 030104 developmental biology, Genes, ras, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Immunohistochemistry, business, Colorectal Neoplasms, Biomarkers, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4937b3b9337afc85a90006c6268b2a74Test
https://hdl.handle.net/11588/920571Test

المؤلفون: Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum'Hamed, Z, Vlassak, S, Studeny, M, Argiles, G, Universitat Autònoma de Barcelona

المساهمون: Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum'Hamed, Z, Vlassak, S, Studeny, M, Argiles, G

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Annals of Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Indoles, chemorefractory metastatic colorectal cancer, Placebo-controlled study, Administration, Oral, law.invention, Placebos, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, nintedanib, angiogenesis inhibition, Hematology, Fatigue, Hazard ratio, Middle Aged, Progression-Free Survival, Angiogenesis inhibition, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Disease Progression, Nintedanib, Female, Chemical and Drug Induced Liver Injury, Colorectal Neoplasms, Adult, medicine.medical_specialty, Antineoplastic Agents, Adenocarcinoma, Placebo, 03 medical and health sciences, Double-Blind Method, Internal medicine, Regorafenib, Gastrointestinal Tumors, medicine, Humans, Progression-free survival, Protein Kinase Inhibitors, neoplasms, Aged, business.industry, Chemorefractory metastatic colorectal cancer, Original Articles, digestive system diseases, 030104 developmental biology, Receptors, Vascular Endothelial Growth Factor, chemistry, business

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41d65dc8d8674d58105961d203252feTest
https://hdl.handle.net/20.500.12530/36062Test

المؤلفون: Floriana Morgillo, Giovanna Esposito, Gianfranco Mancuso, Francesco Perrone, Fortunato Ciardiello, Maria Carmela Piccirillo, Paolo Maione, Clorinda Schettino, Cesare Gridelli, Raimondo Di Liello, Piera Gargiulo, Vittorio Gebbia, Giuliano Palumbo, Massimo Di Maio, Adriano Gravina, Alessia Spagnuolo, Laura Arenare, Alessandro Morabito, Carminia Maria Della Corte, Ciro Gallo

المساهمون: Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., Della Corte, C. M., Morgillo, F., Mancuso, G., Di Liello, R., Gravina, A., Schettino, C., Di Maio, M., Gallo, C., Perrone, F., Piccirillo, M. C.

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Retrospective-prospective design, Lung Neoplasms, law.invention, Chemotherapy-induced neutropenia (CIN), Lung cancer, Overall survival, Prognostic factors, 0302 clinical medicine, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, Prospective Studies, RC254-282, Randomized Controlled Trials as Topic, Prognostic factor, education.field_of_study, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030220 oncology & carcinogenesis, Female, medicine.medical_specialty, Neutropenia, Population, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, Genetics, medicine, Humans, education, neoplasms, Aged, Retrospective Studies, Proportional hazards model, business.industry, Research, Cancer, medicine.disease, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56845084e8de5aa8b4753e0081aedf5cTest
https://doaj.org/article/a4ff3976bddf475882f1ba7ca7d1a374Test

المؤلفون: Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, Sara Lonardi, Fotios Loupakis, Filippo Pietrantonio, Roberto Bordonaro, Tiziana Pia Latiano, Emiliano Tamburini, Daniele Santini, Alessandro Passardi, Federica Marmorino, Roberta Grande, Giuseppe Aprile, Alberto Zaniboni, Sabina Murgioni, Cristina Granetto, Angela Buonadonna, Roberto Moretto, Salvatore Corallo, Stefano Cordio, Lorenzo Antonuzzo, Gianluca Tomasello, Gianluca Masi, Monica Ronzoni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Giuliana Ritorto, Andrea Mambrini, Mario Roselli, Samanta Cupini, Serafina Mammoliti, Elisabetta Fenocchio, Enrichetta Corgna, Vittorina Zagonel, Gabriella Fontanini, Clara Ugolini, Luca Boni, Alfredo Falcone, Filippo Guglielmo Maria De Braud, Evaristo Maiello, Giovanni Luca Frassineti, Teresa Gamucci, Francesco Di Costanzo, Luca Gianni, Patrizia Racca, Giacomo Allegrini, Alberto Sobrero, Massimo Aglietta, Enrico Cortesi, Domenico Cristiano Corsi, Alberto Ballestrero, Andrea Bonetti, Francesco Di Clemente, Enzo Ruggeri, Fortunato Ciardiello, Marco Benasso, Stefano Vitello, Saverio Cinieri, Stefania Mosconi, Nicola Silvestris, Antonio Frassoldati, Samantha Cupini, Alessandro Bertolini, Giampaolo Tortora, Carmelo Bengala, Daris Ferrari, Antonia Ardizzoia, Carlo Milandri, Silvana Chiara, Gianpiero Romano, Stefania Miraglia, Laura Scaltriti, Francesca Pucci, Livio Blasi, Silvia Brugnatelli, Luisa Fioretto, Angela Stefania Ribecco, Raffaella Longarini, Michela Frisinghelli, Maria Banzi

المساهمون: Cremolini, C., Antoniotti, C., Rossini, D., Lonardi, S., Loupakis, F., Pietrantonio, F., Bordonaro, R., Latiano, T. P., Tamburini, E., Santini, D., Passardi, A., Marmorino, F., Grande, R., Aprile, G., Zaniboni, A., Murgioni, S., Granetto, C., Buonadonna, A., Moretto, R., Corallo, S., Cordio, S., Antonuzzo, L., Tomasello, G., Masi, G., Ronzoni, M., Di Donato, S., Carlomagno, C., Clavarezza, M., Ritorto, G., Mambrini, A., Roselli, M., Cupini, S., Mammoliti, S., Fenocchio, E., Corgna, E., Zagonel, V., Fontanini, G., Ugolini, C., Boni, L., Falcone, A., De Braud, F. G. M., Maiello, E., Frassineti, G. L., Gamucci, T., Di Costanzo, F., Gianni, L., Racca, P., Allegrini, G., Sobrero, A., Aglietta, M., Cortesi, E., Corsi, D. C., Ballestrero, A., Bonetti, A., Di Clemente, F., Ruggeri, E., Ciardiello, F., Benasso, M., Vitello, S., Cinieri, S., Mosconi, S., Silvestris, N., Frassoldati, A., Bertolini, A., Tortora, G., Bengala, C., Ferrari, D., Ardizzoia, A., Milandri, C., Chiara, S., Romano, G., Miraglia, S., Scaltriti, L., Pucci, F., Blasi, L., Brugnatelli, S., Fioretto, L., Ribecco, A. S., Longarini, R., Frisinghelli, M., Banzi, M.

المصدر: The Lancet Oncology. 21:497-507

مصطلحات موضوعية: Male, 0301 basic medicine, GONO, Organoplatinum Compounds, multicentre, Leucovorin, Colorectal Neoplasm, Gastroenterology, Settore MED/06, Antineoplastic Agents, Immunological, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, FOLFOXIRI, progression versus mFOLFOX6 plus bevacizumab, mFOLFOX6, metastatic colorectal cancer, Middle Aged, TRIBE2 trial, FOLFIRI plus bevacizumab, Neoplasm Metastasi, Bevacizumab, FOLFOXIRI plus bevacizumab, triplet FOLFOXIRI, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, Disease Progression, FOLFIRI, Female, metastatic colorectal cancer, triplet FOLFOXIRI , FOLFOXIRI plus bevacizumab, FOLFIRI plus bevacizumab, progression versus mFOLFOX6 plus bevacizumab, TRIBE2, Colorectal Neoplasms, Human, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Analogs & derivatives, open-label, NO, Young Adult, 03 medical and health sciences, Folinic acid, Internal medicine, medicine, cancer, Humans, neoplasms, Aged, Antineoplastic Combined Chemotherapy Protocol, Performance status, business.industry, Organoplatinum Compound, randomised controlled, FOLFOXIRI, bevacizumab, mFOLFOX6, FOLFIRI, metastatic colorectal cancer, TRIBE2 trial, multicentre, open-label, phase 3, randomised controlled, GONO, Irinotecan, 030104 developmental biology, phase 3, TRIBE2, Camptothecin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c063b870a6358d03a96a6c6d9271c5Test
https://doi.org/10.1016/s1470-2045Test(19)30862-9

المؤلفون: Stefania Napolitano, Vincenzo Famiglietti, Vincenzo De Falco, J. Ros, Elena Elez Fernandez, Pietro Paolo Vitiello, Fortunato Ciardiello, Evaristo Maiello, Tiziana Latiano, Teresa Troiani, Giulia Martini, Davide Ciardiello, Erika Martinelli

المساهمون: Institut Català de la Salut, [Ciardiello D] Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy. Oncologia Medica, Ospedale Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy. [Martini G, Famiglietti V, Napolitano S, De Falco V, Troiani T] Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy. [Ros J] Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, 08035 Barcelona, Spain. [Elez Fernandez E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, 08035 Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Ciardiello, D., Martini, G., Famiglietti, V., Napolitano, S., De Falco, V., Troiani, T., Latiano, T. P., Ros, J., Fernandez, E. E., Vitiello, P. P., Maiello, E., Ciardiello, F., Martinelli, E.

المصدر: Scientia
Cancers
Cancers, Vol 13, Iss 1941, p 1941 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, rechallenge, anti-EGFR monoclonal antibodies, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Review, Other subheadings::Other subheadings::/drug therapy [Other subheadings], 03 medical and health sciences, 0302 clinical medicine, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES], Growth factor receptor, Metàstasi, Anti-EGFR monoclonal antibodie, Internal medicine, Recte - Càncer - Tractament, Medicine, Panitumumab, Còlon - Càncer -Tractament, Other subheadings::/therapeutic use [Other subheadings], Liquid biopsy, RC254-282, Chemotherapy, Cetuximab, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], metastatic colorectal cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], medicine.disease, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES], 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer cell, Biomarker (medicine), Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d23bbe392ea27e821274084d713013Test
https://hdl.handle.net/11351/6741Test

المؤلفون: Takayuki Yoshino, Ashwin Gollerkeri, Tormod Kyrre Guren, K. Maharry, Hendrik Tobias Arkenau, Fortunato Ciardiello, Neeltje Steeghs, Pilar García-Alfonso, Josep Tabernero, Eric Van Cutsem, Jayesh Desai, Scott Kopetz, Fotios Loupakis, Janna Christy-Bittel, Rona Yaeger, Elena Elez, Yong Sang Hong, Harpreet Wasan, Axel Grothey

المساهمون: Institut Català de la Salut, [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Grothey A] West Cancer Center, OneOncology, Germantown, TN. [Van Cutsem E] University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. [Yaeger R] Memorial Sloan-Kettering Cancer Center, New York, NY. [Wasan H] Hammersmith Hospital, Department of Cancer Medicine, Imperial College London, London, United Kingdom. [Yoshino T] National Cancer Center Hospital East, Kashiwa, Japan, Vall d'Hebron Barcelona Hospital Campus, Tabernero, J., Grothey, A., van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y. S., Steeghs, N., Guren, T. K., Arkenau, H. -T., Garcia-Alfonso, P., Elez, E., Gollerkeri, A., Maharry, K., Christy-Bittel, J., Kopetz, S.

المصدر: Scientia
Journal of Clinical Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Intestí gros - Càncer, Colorectal cancer, Cetuximab, chemistry.chemical_compound, 0302 clinical medicine, Encorafenib, Gastrointestinal Cancer, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Aged, 80 and over, Sulfonamides, Binimetinib, Standard of Care, Middle Aged, Prognosis, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES], Survival Rate, 030220 oncology & carcinogenesis, FOLFIRI, Female, Colorectal Neoplasms, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, 03 medical and health sciences, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES], Internal medicine, RAPID COMMUNICATIONS, medicine, Humans, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Survival rate, Aged, Medicaments antineoplàstics - Ús terapèutic - Eficàcia, business.industry, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], digestive system diseases, Clinical trial, Irinotecan, 030104 developmental biology, chemistry, Mutation, Carbamates, business, Follow-Up Studies

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b794b16b7cce9f9668d73f1cac67945dTest
https://hdl.handle.net/11351/6118Test

المؤلفون: Alain Hendlisz, Luigi Moretti, Francesco Sclafani, Andrea Pretta, Amélie Deleporte, Fortunato Ciardiello, Teresa Troiani, A.M. Bali, Emilio Francesco Giunta, Gabriel Liberale, Giacomo Bregni

المساهمون: Giunta, E. F., Bregni, G., Pretta, A., Deleporte, A., Liberale, G., Bali, A. M., Moretti, L., Troiani, T., Ciardiello, F., Hendlisz, A., Sclafani, F.

المصدر: Cancer treatment reviews, 96

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, RAPIDO, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Total neoadjuvant therapy, Locally advanced, Leucovorin, Consolidation chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Stage (cooking), Rectal cancer, Intensive care medicine, Imagerie médicale, radiologie, tomographie, Neoadjuvant therapy, Capecitabine, Neoplasm Staging, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocol, PRODIGE 23, business.industry, Rectal Neoplasms, Organoplatinum Compound, Induction chemotherapy, Consolidation Chemotherapy, General Medicine, Chemoradiotherapy, medicine.disease, Neoadjuvant Therapy, Radiation therapy, Cancérologie, Oxaliplatin, 030104 developmental biology, Oncology, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Fluorouracil, business, Human

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f6b0afe7a19341ee1ea85e2f676ab4Test
https://pubmed.ncbi.nlm.nih.gov/33798955Test

المؤلفون: Valentina Belli, Stefania Napolitano, Virginia Tirino, Pietro Paolo Vitiello, Emilio Francesco Giunta, Nunzia Matrone, Carminia Maria Della Corte, Vincenzo Desiderio, Giulia Martini, Claudia Cardone, Davide Ciardiello, Luigi Mele, L. Poliero, Floriana Morgillo, Vincenzo De Falco, Fortunato Ciardiello, Teresa Troiani, Erika Martinelli, Francesco Selvaggi, Gianpaolo Papaccio

المساهمون: Vitiello, P. P., Martini, G., Mele, L., Giunta, E. F., De Falco, V., Ciardiello, D., Belli, V., Cardone, C., Matrone, N., Poliero, L., Tirino, V., Napolitano, S., Della Corte, C., Selvaggi, F., Papaccio, G., Troiani, T., Morgillo, F., Desiderio, V., Ciardiello, F., Martinelli, E.

المصدر: Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-15 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Indazoles, Colorectal cancer, DNA damage, medicine.medical_treatment, Mice, Nude, DNA damage response, Irinotecan, lcsh:RC254-282, 03 medical and health sciences, Mice, 0302 clinical medicine, Piperidines, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, Humans, Homologous recombination, Clonogenic assay, PARP inhibitors, Chemotherapy, business.industry, Research, Synergism, Drug interaction, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, digestive system diseases, Oxaliplatin, 030104 developmental biology, PARP inhibitor, Oncology, 030220 oncology & carcinogenesis, Combination treatment, Mutation, Chemopotentiation, Cancer research, Female, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52510dbd20786bc02b7423845f723e19Test
http://hdl.handle.net/11591/444303Test

المؤلفون: Elena Elez, Taito Esaki, Destiny-Crc investigators, Fortunato Ciardiello, Kanwal Pratap Singh Raghav, Fotios Loupakis, Takayuki Yoshino, Eriko Yamamoto, Tomohiro Nishina, Kapil Saxena, Maria Di Bartolomeo, Javier Rodríguez, Axel Grothey, Yasuyuki Okuda, Hisato Kawakami, Zev A. Wainberg, Andrea Sartore-Bianchi, Salvatore Siena, Emarjola Bako, Javad Shahidi, Marwan Fakih, Kensei Yamaguchi, Toshiki Masuishi, Ki Y Chung, Yoshito Komatsu

المساهمون: Siena, S., Di Bartolomeo, M., Raghav, K., Masuishi, T., Loupakis, F., Kawakami, H., Yamaguchi, K., Nishina, T., Fakih, M., Elez, E., Rodriguez, J., Ciardiello, F., Komatsu, Y., Esaki, T., Chung, K., Wainberg, Z., Sartore-Bianchi, A., Saxena, K., Yamamoto, E., Bako, E., Okuda, Y., Shahidi, J., Grothey, A., Yoshino, T.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Immunoconjugates, Maximum Tolerated Dose, Colorectal cancer, Receptor, ErbB-2, Phases of clinical research, Colorectal Neoplasm, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Japan, Trastuzumab, Internal medicine, medicine, Clinical endpoint, Humans, Neoplasm Metastasis, Pneumonitis, Aged, business.industry, Standard treatment, Middle Aged, medicine.disease, Clinical trial, Neoplasm Metastasi, 030104 developmental biology, Immunoconjugate, Italy, Spain, 030220 oncology & carcinogenesis, Cohort, Camptothecin, Female, business, Colorectal Neoplasms, medicine.drug, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4b3fdedcfcda48de0a082e048db43fTest
http://hdl.handle.net/11591/452991Test

المؤلفون: Diego Signorelli, A. Prelaj, Benedetta Trevisan, Giacomo Massa, Giulia Galli, Marina Chiara Garassino, Carminia Maria Della Corte, Claudia Proto, Floriana Morgillo, Francesca Sparano, Giuseppe Lo Russo, Filippo de Braud, Raimondo Di Liello, Fortunato Ciardiello, Giuseppe Viscardi, Marta Brambilla, Maria Lucia Iacovino, Alessandro De Toma, Monica Ganzinelli, Roberto Ferrara, Riccardo Lobefaro

المساهمون: Lobefaro, R., Viscardi, G., Di Liello, R., Massa, G., Iacovino, M. L., Sparano, F., Della Corte, C. M., Ferrara, R., Signorelli, D., Proto, C., Prelaj, A., Galli, G., De Toma, A., Brambilla, M., Ganzinelli, M., Trevisan, B., Ciardiello, F., De Braud, F., Morgillo, F., Garassino, M. C., Lo Russo, G.

المصدر: Lung cancer (Amsterdam, Netherlands). 152

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Unfit, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, ECOG Performance Status, law.invention, 03 medical and health sciences, 0302 clinical medicine, Text mining, Randomized controlled trial, law, Retrospective Studie, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Progression-free survival, Lung cancer, Pathological, Poor performance statu, Poor performance status, Retrospective Studies, business.industry, Immunotherapy, Biomarker, medicine.disease, Non-Small Cell Lung Cancer, 030104 developmental biology, 030220 oncology & carcinogenesis, Patient survival, Female, Non small cell, Safety, business, Biomarkers, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e518328ecb3ba195d256beb056bb72faTest
https://pubmed.ncbi.nlm.nih.gov/33421923Test